IQVIA Holdings Inc (IQV) - Net Assets
Based on the latest financial reports, IQVIA Holdings Inc (IQV) has net assets worth $6.50 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($29.94 Billion) and total liabilities ($23.44 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are IQVIA Holdings Inc's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.50 Billion |
| % of Total Assets | 21.72% |
| Annual Growth Rate | N/A |
| 5-Year Change | 9.73% |
| 10-Year Change | -25.17% |
| Growth Volatility | 7.43 |
IQVIA Holdings Inc - Net Assets Trend (2011–2025)
This chart illustrates how IQVIA Holdings Inc's net assets have evolved over time, based on quarterly financial data. Also explore IQVIA Holdings Inc asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for IQVIA Holdings Inc (2011–2025)
The table below shows the annual net assets of IQVIA Holdings Inc from 2011 to 2025. For live valuation and market cap data, see how much is IQVIA Holdings Inc worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $6.63 Billion | +9.28% |
| 2024-12-31 | $6.07 Billion | -0.74% |
| 2023-12-31 | $6.11 Billion | +6.02% |
| 2022-12-31 | $5.76 Billion | -4.58% |
| 2021-12-31 | $6.04 Billion | -3.79% |
| 2020-12-31 | $6.28 Billion | +0.27% |
| 2019-12-31 | $6.26 Billion | -9.94% |
| 2018-12-31 | $6.95 Billion | -16.80% |
| 2017-12-31 | $8.36 Billion | -5.67% |
| 2016-12-31 | $8.86 Billion | +2739.41% |
| 2015-12-31 | $-335.68 Million | +52.32% |
| 2014-12-31 | $-704.01 Million | -5.47% |
| 2013-12-31 | $-667.49 Million | +50.89% |
| 2012-12-31 | $-1.36 Billion | -40.17% |
| 2011-12-31 | $-969.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to IQVIA Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 841941500000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $7.42 Billion | 114.18% |
| Common Stock | $11.38 Billion | 174.97% |
| Other Comprehensive Income | $-943.00 Million | -14.50% |
| Total Equity | $6.50 Billion | 100.00% |
IQVIA Holdings Inc Competitors by Market Cap
The table below lists competitors of IQVIA Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Restaurant Brands International Inc
TO:QSR
|
$27.30 Billion |
|
ZIJIN MIN.H UNSP.ADR/20
F:FJZB
|
$27.31 Billion |
|
China Merchants Bank Co. Ltd
F:M4B
|
$27.39 Billion |
|
ON Semiconductor Corporation
NASDAQ:ON
|
$27.40 Billion |
|
KB Financial Group Inc
F:KBIA
|
$27.25 Billion |
|
Shengyi Technology Co Ltd
SHG:600183
|
$27.20 Billion |
|
Shenzhen Inovance Tech
SHE:300124
|
$27.18 Billion |
|
Hexagon AB (publ)
ST:HEXA-B
|
$27.18 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in IQVIA Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,067,000,000 to 6,503,000,000, a change of 436,000,000 (7.2%).
- Net income of 1,360,000,000 contributed positively to equity growth.
- Share repurchases of 1,244,000,000 reduced equity.
- Other comprehensive income increased equity by 95,000,000.
- Other factors increased equity by 225,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.36 Billion | +20.91% |
| Share Repurchases | $1.24 Billion | -19.13% |
| Other Comprehensive Income | $95.00 Million | +1.46% |
| Other Changes | $225.00 Million | +3.46% |
| Total Change | $- | 7.19% |
Book Value vs Market Value Analysis
This analysis compares IQVIA Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.29x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | $-7.61 | $160.94 | x |
| 2012-12-31 | $-10.66 | $160.94 | x |
| 2013-12-31 | $-5.22 | $160.94 | x |
| 2014-12-31 | $-5.37 | $160.94 | x |
| 2015-12-31 | $-2.67 | $160.94 | x |
| 2016-12-31 | $56.80 | $160.94 | x |
| 2017-12-31 | $36.43 | $160.94 | x |
| 2018-12-31 | $32.25 | $160.94 | x |
| 2019-12-31 | $30.08 | $160.94 | x |
| 2020-12-31 | $30.77 | $160.94 | x |
| 2021-12-31 | $30.98 | $160.94 | x |
| 2022-12-31 | $30.25 | $160.94 | x |
| 2023-12-31 | $32.81 | $160.94 | x |
| 2024-12-31 | $33.08 | $160.94 | x |
| 2025-12-31 | $37.48 | $160.94 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently IQVIA Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.91%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.34%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 4.60x
- Recent ROE (20.91%) is above the historical average (8.66%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | 5.59% | 1.86x | 0.00x | $338.81 Million |
| 2012 | 0.00% | 3.65% | 1.95x | 0.00x | $313.50 Million |
| 2013 | 0.00% | 4.44% | 1.66x | 0.00x | $293.33 Million |
| 2014 | 0.00% | 6.53% | 1.65x | 0.00x | $426.78 Million |
| 2015 | 0.00% | 6.75% | 1.46x | 0.00x | $420.77 Million |
| 2016 | 1.33% | 1.69% | 0.32x | 2.46x | $-748.30 Million |
| 2017 | 16.14% | 13.49% | 0.43x | 2.80x | $498.10 Million |
| 2018 | 3.86% | 2.49% | 0.46x | 3.36x | $-412.40 Million |
| 2019 | 3.18% | 1.72% | 0.48x | 3.87x | $-409.30 Million |
| 2020 | 4.65% | 2.46% | 0.46x | 4.09x | $-321.10 Million |
| 2021 | 15.99% | 6.96% | 0.56x | 4.09x | $361.80 Million |
| 2022 | 18.92% | 7.57% | 0.57x | 4.39x | $514.50 Million |
| 2023 | 22.22% | 9.06% | 0.56x | 4.37x | $746.80 Million |
| 2024 | 22.63% | 8.91% | 0.57x | 4.43x | $766.30 Million |
| 2025 | 20.91% | 8.34% | 0.54x | 4.60x | $709.70 Million |
Industry Comparison
This section compares IQVIA Holdings Inc's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $308,178,166
- Average return on equity (ROE) among peers: -121.93%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| IQVIA Holdings Inc (IQV) | $6.50 Billion | 0.00% | 3.60x | $27.30 Billion |
| Agilent Technologies Inc (A) | $3.66 Billion | 90.38% | 1.01x | $31.75 Billion |
| Advanced Biomed Inc. Common Stock (ADVB) | $1.31 Million | -285.91% | 2.52x | $8.13 Million |
| Applied DNA Sciences Inc (APDN) | $-995.38K | 0.00% | 0.00x | $3.99 Million |
| Biodesix Inc (BDSX) | $19.73 Million | -218.78% | 2.86x | $79.44 Million |
| bioAffinity Technologies, Inc. (BIAF) | $2.60 Million | -347.42% | 1.50x | $9.81 Million |
| Biocept Inc. (BIOCQ) | $23.69 Million | -75.16% | 1.00x | $262.00 |
| BillionToOne, Inc. Class A Common Stock (BLLN) | $167.75 Million | -24.78% | 0.80x | $2.99 Billion |
| Burning Rock Biotech Ltd (BNR) | $-891.49 Million | 0.00% | 0.00x | $155.30 Million |
| CareDx Inc (CDNA) | $99.00 Million | -22.19% | 0.53x | $1.00 Billion |
| Check Cap Ltd (CHEK) | $1.19 Million | -335.43% | 3.51x | $9.42 Million |
About IQVIA Holdings Inc
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment of… Read more